Corrigendum: Antibody-antigen kinetics constrain intracellular humoral immunity (Scientific Reports (2017) 6 (37457) DOI: 10.1038/srep37457);Antibody-antigen kinetics constrain intracellular humoral immunity

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Bottermann, Maria ^a   Lode, Heidrun Elisabeth ^b   Watkinson, Ruth E ^c   Foss, Stian ^b   Sandlie, Inger ^b   Andersen, Jan Terje ^b   James, Leo C ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b UNIVERSITY OF OSLO   (Norway)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN F(AB) FRAGMENT; NEUTRALIZING ANTIBODY; PROTEIN BINDING; RECOMBINANT PROTEIN; RIBONUCLEOPROTEIN; SS-A ANTIGEN; VIRUS ANTIGEN;

ALPHA HELIX; ANTIBODY AFFINITY; BETA SHEET; BINDING SITE; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION; GENE VECTOR; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEK293 CELL LINE; HUMAN; HUMAN ADENOVIRUS C; HUMORAL IMMUNITY; IMMUNOLOGY; KINETICS; METABOLISM; MOLECULAR CLONING; MOLECULAR MODEL; PROTEIN DOMAIN; PROTEIN ENGINEERING; SERODIAGNOSIS; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

ADENOVIRUSES, HUMAN; ANTIBODIES, NEUTRALIZING; ANTIBODY AFFINITY; ANTIGENS, VIRAL; BINDING SITES; CLONING, MOLECULAR; CRYSTALLOGRAPHY, X-RAY; GENE EXPRESSION; GENETIC VECTORS; HEK293 CELLS; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN FAB FRAGMENTS; KINETICS; MODELS, MOLECULAR; NEUTRALIZATION TESTS; NF-KAPPA B; PROTEIN BINDING; PROTEIN CONFORMATION, ALPHA-HELICAL; PROTEIN CONFORMATION, BETA-STRAND; PROTEIN ENGINEERING; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECOMBINANT PROTEINS; RIBONUCLEOPROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84997497036     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep45418     Document Type: Erratum

References (30)

1. James, L. C., Keeble, A. H., Khan, Z., Rhodes, D. A., Trowsdale, J. Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function. Proc Natl Acad Sci USA 104, 6200-6205, doi: 10. 1073/pnas. 0609174104 (2007).
2. Keeble, A. H., Khan, Z., Forster, A., James, L. C. TRIM21 is an IgG receptor that is structurally, thermodynamically, kinetically conserved. Proc Natl Acad Sci USA 105, 6045-6050, doi: 10. 1073/pnas. 0800159105 (2008).
3. Mallery, D. L. et al. Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc Natl Acad Sci USA 107, 19985-19990, doi: 10. 1073/pnas. 1014074107 (2010).
4. Hauler, F., Mallery, D. L., McEwan, W. A., Bidgood, S. R., James, L. C. AAA ATPase p97/VCP is essential for TRIM21-mediated virus neutralization. Proc Natl Acad Sci USA 109, 19733-19738, doi: 10. 1073/pnas. 1210659109 (2012).
5. Fletcher, A. J., Mallery, D. L., Watkinson, R. E., Dickson, C. F., James, L. C. Sequential ubiquitination and deubiquitination enzymes synchronize the dual sensor and effector functions of TRIM21. Proc Natl Acad Sci USA, doi: 10. 1073/pnas. 1507534112 (2015).
6. McEwan, W. A. et al. Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21. Nat Immunol 14, 327-336, doi: 10. 1038/ni. 2548 (2013).
7. Fan, W. et al. Swine TRIM21 restricts FMDV infection via an intracellular neutralization mechanism. Antiviral Res 127, 32-40, doi: 10. 1016/j. antiviral. 2016. 01. 004 (2016).
8. Rakebrandt, N., Lentes, S., Neumann, H., James, L. C., Neumann-Staubitz, P. Antibody-and TRIM21-dependent intracellular restriction of Salmonella enterica. Pathog Dis 72, 131-137, doi: 10. 1111/2049-632X. 12192 (2014).
9. Watkinson, R. E., McEwan, W. A., Tam, J. C., Vaysburd, M., James, L. C. TRIM21 Promotes cGAS and RIG-I Sensing of Viral Genomes during Infection by Antibody-Opsonized Virus. PLoS Pathog 11, e1005253, doi: 10. 1371/journal. ppat. 1005253 (2015).
10. Vaysburd, M. et al. Intracellular antibody receptor TRIM21 prevents fatal viral infection. Proceedings of the National Academy of Sciences of the United States of America 110, 12397-12401, doi: 10. 1073/pnas. 1301918110 (2013).
11. McEwan, W. A. et al. Regulation of virus neutralization and the persistent fraction by TRIM21. Journal of virology 86, 8482-8491, doi: 10. 1128/JVI. 00728-12 (2012).
12. Varghese, R., Mikyas, Y., Stewart, P. L., Ralston, R. Postentry neutralization of adenovirus type 5 by an antihexon antibody. Journal of virology 78, 12320-12332, doi: 10. 1128/JVI. 78. 22. 12320-12332. 2004 (2004).
13. Rux, J. J., Burnett, R. M. Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon. Molecular therapy: the journal of the American Society of Gene Therapy 1, 18-30, doi: 10. 1006/mthe. 1999. 0001 (2000).
14. Rux, J. J., Kuser, P. R., Burnett, R. M. Structural and Phylogenetic Analysis of Adenovirus Hexons by Use of High-Resolution X-Ray Crystallographic, Molecular Modeling, Sequence-Based Methods. Journal of virology 77, 9553-9566, doi: 10. 1128/jvi. 77. 17. 9553-9566. 2003 (2003).
15. Crawford-Miksza, L., Schnurr, D. P. Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues. Journal of virology 70, 1836-1844 (1996).
16. Gallivan, J. P., Dougherty, D. A. Cation-pi interactions in structural biology. Proceedings of the National Academy of Sciences 96, 9459-9464 (1999).
17. Foss, S. et al. TRIM21 Immune Signaling Is More Sensitive to Antibody Affinity Than Its Neutralization Activity. Journal of immunology 196, 3452-3459, doi: 10. 4049/jimmunol. 1502601 (2016).
18. Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8, 2281-2308, doi: 10. 1038/nprot. 2013. 143 (2013).
19. Bidgood, S. R., Tam, J. C., McEwan, W. A., Mallery, D. L., James, L. C. Translocalized IgA mediates neutralization and stimulates innate immunity inside infected cells. Proceedings of the National Academy of Sciences of the United States of America 111, 13463-13468, doi: 10. 1073/pnas. 1410980111 (2014).
20. Khurana, S. et al. H5 N-terminal beta sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine. Vaccine 32, 6421-6432, doi: 10. 1016/j. vaccine. 2014. 09. 049 (2014).
21. Batista, F. D., Neuberger, M. S. Affinity dependence of the B cell response to antigen: a threshold, a ceiling, the importance of off-rate. Immunity 8, 751-759 (1998).
22. Foote, J., Eisen, H. N. Kinetic and affinity limits on antibodies produced during immune responses. Proceedings of the National Academy of Sciences of the United States of America 92, 1254-1256 (1995).
23. Poulsen, T. R., Jensen, A., Haurum, J. S., Andersen, P. S. Limits for antibody affinity maturation and repertoire diversification in hypervaccinated humans. Journal of immunology 187, 4229-4235, doi: 10. 4049/jimmunol. 1000928 (2011).
24. Kwong, P. D. et al. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 420, 678-682 (2002).
25. Klasse, P. J. How to assess the binding strength of antibodies elicited by vaccination against HIV and other viruses. Expert Rev Vaccines 15, 295-311, doi: 10. 1586/14760584. 2016. 1128831 (2016).
26. Ylera, F., Harth, S., Waldherr, D., Frisch, C., Knappik, A. Off-rate screening for selection of high-affinity anti-drug antibodies. Analytical biochemistry 441, 208-213, doi: 10. 1016/j. ab. 2013. 07. 025 (2013).
27. Foss, S. et al. TRIM21 Immune Signaling Is More Sensitive to Antibody Affinity Than Its Neutralization Activity. Journal of immunology, doi: 10. 4049/jimmunol. 1502601 (2016).
28. Collaborative Computational Project, N. The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50, 760-763 (1994).
29. McCoy, A. J. et al. Phaser crystallographic software. Journal of Applied Crystallography 40, 658-674, doi: 10. 1107/S0021889807021206 (2007).
30. Emsley, P., Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60, 2126-2132, doi: 10. 1107/S0907444904019158 (2004).